DAX24.272 +0,4%Est505.652 +0,8%MSCI World4.307 +0,1%Top 10 Crypto15,00 -1,5%Nas22.656 -0,1%Bitcoin92.911 -2,3%Euro1,1690 +0,4%Öl62,14 -0,5%Gold4.226 +0,4%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 DroneShield A2DMAA NVIDIA 918422 RENK RENK73 D-Wave Quantum A3DSV9 Plug Power A1JA81 AMD (Advanced Micro Devices) 863186 HENSOLDT HAG000 NEL ASA A0B733 European Lithium A2AR9A BASF BASF11 Siemens Energy ENER6Y Tesla A1CX3T Novo Nordisk A3EU6F Amazon 906866
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Handelsstreit weiter im Blick: DAX schließt freundlich -- Merck vor nächster Wachstumsphase -- Rheinmetall, RENK, HENSOLDT, DroneShield, Gold, Micron, TSMC, D-Wave im Fokus
Top News
Handelsstreit bleibt Hauptthema: DAX rettet am Donnerstag späte Gewinne in den Feierabend Handelsstreit bleibt Hauptthema: DAX rettet am Donnerstag späte Gewinne in den Feierabend
Interview: Carmignac Sécurité - In allen Marktphasen stabile Erträge mit begrenzter Volatilität Interview: Carmignac Sécurité - In allen Marktphasen stabile Erträge mit begrenzter Volatilität
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Danaher Aktie

Kaufen
Verkaufen
Danaher Aktien-Sparplan
178,98 EUR +1,58 EUR +0,89 %
STU
211,37 USD +5,29 USD +2,57 %
BTT
Danaher jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.126,66 Mrd. EUR

KGV43,40Div. Rendite0,47%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN866197

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS2358511028

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolDHR

Danaher Aktien News

DatumMeistgelesen
PR NewswireDanaher to Acquire Abcam
PR NewswireSHAREHOLDER ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 15, 2023 in the Class Action Filed on Behalf of Danaher Corporation (DHR) Shareholders
PR NewswireDanaher Declares pro Rata Dividend of Veralto Common Stock and Announces Expected "When-issued" Trading of Veralto Common Stock
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Danaher Corporation of Class Action Lawsuit and Upcoming Deadline - DHR
PR NewswireROSEN, A LEADING LAW FIRM, Encourages Danaher Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - DHR
PR NewswireDanaher Releases 2023 Sustainability Report
PR NewswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Danaher Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 15, 2023 - (NYSE: DHR)
PR NewswireROSEN, NATIONAL INVESTOR COUNSEL, Encourages Danaher Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - DHR
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Danaher Corporation of Class Action Lawsuit and Upcoming Deadline - DHR
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Danaher Corporation of Class Action Lawsuit and Upcoming Deadline - DHR
PR NewswireCLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Danaher Investors of a Lead Plaintiff Deadline of September 15, 2023
PR NewswireROSEN, A LEADING LAW FIRM, Encourages Danaher Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - DHR
PR NewswireSHAREHODER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Danaher Corporation of Class Action Lawsuit and Upcoming Deadline - DHR
PR NewswireBeckman Coulter's DxI 9000 Immunoassay Analyzer with Increased Assay Development Sensitivity Makes First North American Appearance at 2023 AACC
PR NewswireBeckman Coulter Receives FDA Clearance for DxC 500 AU Chemistry Analyzer, Expanding Portfolio with Proven Six Sigma Performance
PR NewswireDanaher Reports Second Quarter 2023 Results
PR NewswireDHR SHAREHOLDER ALERT: Jakubowitz Law Reminds Danaher Shareholders of a Lead Plaintiff Deadline of September 15, 2023
PR NewswireDHR LAWSUIT ALERT: Levi & Korsinsky Notifies Danaher Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
PR NewswireCalling All Danaher Corporation (DHR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit!
PR NewswirePomerantz Law Firm Announces the Filing of a Class Action Against Danaher Corporation and Certain Officers - DHR
PR NewswireBeckman Coulter and Fujirebio Partner to Bolster Access to Patient-friendly, Blood-based Alzheimer's Disease Test
PR NewswireDanaher Schedules Second Quarter 2023 Earnings Conference Call
PR NewswireBeckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance with No Daily Maintenance
PR NewswireBeckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance with No Daily Maintenance
PR NewswireBeckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance with No Daily Maintenance
PR NewswireBeckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance with No Daily Maintenance
PR NewswireBeckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance with No Daily Maintenance
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Danaher Corporation - DHR
PR NewswireDanaher Announces Quarterly Dividend
PR NewswireDanaher to Present at Bank of America Securities Health Care Conference
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Danaher Corporation - DHR
PR NewswireALDEVRON ANNOUNCES EXPANSION OF mRNA PRODUCTION CAPABILITY
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Danaher Corporation - DHR
PR NewswireDanaher Reports First Quarter 2023 Results
PR NewswireDanaher Announces Conversion Date for Series B Mandatory Convertible Preferred Stock
PR NewswireDanaher Schedules First Quarter 2023 Earnings Conference Call
PR NewswireDanaher Partners with the University of Pennsylvania's Center for Cellular Immunotherapies to Address Manufacturing Challenges Impacting the Uptake of Cell Therapies
PR NewswireDanaher Announces Quarterly Dividends
PR NewswireDanaher Announces New Environmental and Applied Solutions Company to Be Named Veralto
PR NewswireDanaher Reports Fourth Quarter and Full Year 2022 Results

Danaher News

Danaher News: auf dieser Seite finden Sie alle Danaher News und Nachrichten zur Danaher Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Danaher News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Danaher News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.